Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease

Ads

You May Also Like

TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs

Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit ...

Agility Health Closes Proposed Transaction with Alliance

GRAND RAPIDS, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility ...

Basilea reports presentation of data on clinical oncology programs BAL101553 and BAL3833 at AACR meeting

Tumor checkpoint controller BAL101553 demonstrates pre-clinical activity in treatment-refractory glioblastoma models as single agent ...